While CD34 shows significant promise as a diagnostic marker for HCC, it is crucial to interpret its expression in conjunction with other clinical and pathological findings, as the sensitivity and specificity of CD34 alone may not be sufficient for a definitive diagnosis, particularly in well-differentiated or early-stage HCC. The gene discussed is CD34; the disease is hepatocellular carcinoma.